On 13 November, WHO published its first guideline on diagnosis, management and follow-up care for children and adolescents up to age 19 with type 1 diabetes. It is intended for health workers, programme managers and policymakers, with particular attention to primary and secondary care in resource-limited settings. [1]

The official overview says its recommendations draw on systematic evidence reviews and cover clinical assessment, insulin, monitoring and complications. The verified development is publication of a professional reference. This is not a new cure or proof that services are immediately available in every country, and it does not replace an individual clinical care plan. [1]